ANKRD22 and non-small cell lung carcinoma: Recently, studies demonstrated that ANKR protein facilitated the development of non-small cell lung cancer (NSCLC), but suppressed the development of prostate cancer, suggesting that ANKRD22 exerts pro-tumor or anti-tumor effects in different tumor types [9].